{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed the impact of behaviour change technique-based interventions"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with intermittent claudication, who are less active than their peers"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either a behaviour change technique-based intervention or standard care as a control."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed the impact of behaviour change technique-based interventions on daily physical activity and clinical outcomes"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in daily physical activity, measured in steps per day, over short-term (<6 months) and maintenance (>6 months) periods."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 allocated to each group, during the recruitment period from January 2020 to June 2021."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "In the short term, the intervention group demonstrated a significant increase in daily physical activity (standardised mean difference = 0.20, 95% CI 0.07 to 0.33, ~473 steps/day) compared to the control group."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "TRIAL REGISTRATION: PROSPERO CRD42020159869."
      },
      "Funding": {
        "score": 1,
        "evidence": "FUNDING: National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR130664)."
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}